Heart health in MPS
Part of Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This study looks at heart structure and function in people with mucopolysaccharidosis (MPS), a rare genetic disorder. It aims to understand how MPS affects the heart over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of MPS (mucopolysaccharidosis) or be a healthy person of the same age and sex to compare.
- Your parent or you must sign a consent form to be in the study.
- You must be able to take part in the study tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies Morquio A (MPS IVA) using non-invasive ways to measure how the body is working, and to better understand why the condition happens. If you have Morquio A, this may help researchers learn more and improve care.
This trial follows people with genetic neurodegenerative (brain-wasting) disorders over time to better understand how the condition changes. The goal is to learn patterns that could help future treatments or care plans.
This trial enrolls people with mucopolysaccharidosis type VII (MPS VII) to track their health over time. It may help your care team better understand how the condition behaves and how monitoring should be done.
This study follows people with MPS, a rare genetic condition, to learn more about the disease over time. If you have a confirmed MPS diagnosis, you may be able to join.
This study follows people with MPS IIIC (Sanfilippo syndrome type C) over time to understand how the disease changes. It does not test a new treatment, but helps researchers learn more about the condition, which could lead to better care in the future.
This study looks at the nutrition of children with mucopolysaccharidosis (MPS) to better understand their dietary needs and health.
Hear when a new MPS I trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.